The 2026 WHO guideline includes managing unhealthy blood fats as part of dementia risk reduction, and adults over 65 can discuss cholesterol history, current levels, and treatment options with a clinician. Dyslipidaemia means unhealthy levels of fats in the blood, including high LDL "bad" cholesterol. The World Health Organization published the second edition on 15 July 2026, updating the 2019 edition, and concluded up to 45% of dementia risk could be prevented or delayed, according to the WHO announcement. The book version is written for clinicians and public-health professionals.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Read the official guidance from Who — Use this primary source to verify the official guidance.
- Read the official guidance from Who — Use this primary source to verify the official guidance.
Table of Contents
- What the guideline says about cholesterol
- Why midlife cholesterol still matters after 65
- What to ask about tests and overall risk
- What to ask about statins and memory
- How to leave with a clear next step
What the guideline says about cholesterol
The WHO Global Dementia Observatory launch summary says the updated guidance lists managing dyslipidaemia alongside obesity, diabetes, hypertension and hearing loss as health conditions tied to dementia risk, according to the launch summary. For readers over 65, this places cholesterol in a small group of medical conditions worth active follow-up. It does not make cholesterol the single cause of memory loss.
The Georgian Medical Journal summary of the WHO second edition describes midlife management of hypertension, diabetes, dyslipidaemia and obesity as conditional recommendations with very low to moderate certainty. Conditional means the benefit can differ from person to person. Clinician judgment matters, especially when health issues compete.
Why midlife cholesterol still matters after 65
The University of Cambridge Public Health summary of the 2024 Lancet Commission says high LDL cholesterol from about age 40 was added as a new risk factor, linked to about 7% of dementia cases worldwide, according to the Commission summary. That finding points to long exposure, not one high reading. It helps explain why a clinician may ask about past levels and past treatment.
A past number still guides present choices. It shows how long vessels and the brain may have faced extra strain. It also helps separate a new concern from a stable, treated pattern.
What to ask about tests and overall risk
Ask how cholesterol fits your wider vascular picture. Blood pressure, diabetes, smoking history, diet, activity, hearing, mood, sleep and memory symptoms all shape the plan. A useful opening is to ask which test to repeat, when to repeat it, and what target fits your age and health.
Bring notes that make the visit concrete: For adults over 65, the WHO-linked package described by the WHO Global Dementia Observatory is multidomain: physical activity, healthy diet, cognitive and social activity, tobacco cessation, less alcohol, plus control of blood pressure, diabetes and cholesterol. Ask which two or three steps would help you most now. Ask what follow-up will show whether they work.
- latest cholesterol results and dates, plus blood pressure and blood sugar results
- full medicine and supplement list, with doses and missed doses
- diet, activity, tobacco and alcohol habits in a normal week
- memory or thinking changes, with examples and start dates
What to ask about statins and memory
Many older adults take a statin. The MedicalXpress report on the FDA action says the FDA required statin labels in 2012 to note rare post-marketing reports of memory loss and confusion, described as generally not serious and reversible after stopping, according to the FDA action report. The practical message is to review memory concerns rather than stop a statin alone.
Ask what benefit the statin is meant to give you, what side effects to watch for, and what to do if thinking seems worse. Mention new forgetfulness, confusion, low mood, poor sleep, thyroid issues, alcohol use and new medicines. Ask whether another drug, dose change or interaction could explain the change.
How to leave with a clear next step
Ask for one written plan with numbers, actions and dates. It can list your current lipid pattern, blood pressure and blood sugar goals, medicine changes, diet and activity targets, and the next test date.
Ask who to contact if symptoms change before that date. Keep the plan where you will use it, such as beside daily medicines. Bring the medicine bottles, test printouts and a short symptom note to the next visit.
You Might Also Like
- At-Home Leqembi vs IV Infusions After the 2026 FDA Decision: Questions People With Mild Cognitive Impairment Can Ask an Alzheimer’s Specialist
- Safety Questions After the 2026 LiBBY Dementia Trial: Why the Findings May Not Change Care Yet for Adult Children
- Early Dementia Diagnosis Economics in the 2026 NIA Report: What Long-Distance Caregivers Can Check in Their Community
